Cyfuse Biomedical K.K. Statistics

Total Valuation

TYO:4892 has a market cap or net worth of JPY 7.71 billion. The enterprise value is 5.51 billion.

Market Cap	7.71B
Enterprise Value	5.51B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

TYO:4892 has 7.89 million shares outstanding. The number of shares has increased by 3.05% in one year.

Current Share Class	n/a
Shares Outstanding	7.89M
Shares Change (YoY)	+3.05%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	13.11%
Owned by Institutions (%)	-0.94%
Float	4.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	142.83
PB Ratio	3.03
P/TBV Ratio	3.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.32
EV / Sales	102.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.18

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.34.

Current Ratio	5.00
Quick Ratio	4.81
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-1.11
Interest Coverage	-89.60

Financial Efficiency

Return on equity (ROE) is -30.36% and return on invested capital (ROIC) is -14.92%.

Return on Equity (ROE)	-30.36%
Return on Assets (ROA)	-14.49%
Return on Invested Capital (ROIC)	-14.92%
Return on Capital Employed (ROCE)	-31.22%
Revenue Per Employee	2.57M
Profits Per Employee	-41.52M
Employee Count	21
Asset Turnover	0.01
Inventory Turnover	0.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.58% in the last 52 weeks. The beta is 1.77, so TYO:4892's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	+38.58%
50-Day Moving Average	1,027.88
200-Day Moving Average	682.85
Relative Strength Index (RSI)	48.98
Average Volume (20 Days)	163,775

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYO:4892 had revenue of JPY 54.00 million and -872.00 million in losses. Loss per share was -108.31.

Revenue	54.00M
Gross Profit	16.00M
Operating Income	-896.00M
Pretax Income	-870.00M
Net Income	-872.00M
EBITDA	-858.00M
EBIT	-896.00M
Loss Per Share	-108.31

Full Income Statement

Balance Sheet

The company has 3.05 billion in cash and 852.00 million in debt, giving a net cash position of 2.20 billion or 278.68 per share.

Cash & Cash Equivalents	3.05B
Total Debt	852.00M
Net Cash	2.20B
Net Cash Per Share	278.68
Equity (Book Value)	2.54B
Book Value Per Share	312.31
Working Capital	2.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -760.00 million and capital expenditures -8.00 million, giving a free cash flow of -768.00 million.

Operating Cash Flow	-760.00M
Capital Expenditures	-8.00M
Free Cash Flow	-768.00M
FCF Per Share	-97.29

Full Cash Flow Statement

Margins

Gross Margin	29.63%
Operating Margin	-1,659.26%
Pretax Margin	-1,611.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYO:4892 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.05%
Shareholder Yield	-3.05%
Earnings Yield	-11.31%
FCF Yield	-9.96%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TYO:4892 has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	n/a